{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T03:30:34Z","timestamp":1709263834735},"reference-count":75,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2008,7,5]],"date-time":"2008-07-05T00:00:00Z","timestamp":1215216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"DOI":"10.1007\/s00393-008-0324-3","type":"journal-article","created":{"date-parts":[[2008,7,3]],"date-time":"2008-07-03T15:24:08Z","timestamp":1215098648000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostik, Therapie und aktuelle Forschungsaspekte ausgew\u00e4hlter chronisch-entz\u00fcndlicher Erkrankungen mit Beteiligung im Kopf-Hals-Bereich","Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement"],"prefix":"10.1007","author":[{"given":"M.","family":"Laudien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ambrosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Till","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Podschun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,5]]},"reference":[{"key":"324_CR1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","volume":"352","author":"The","year":"2005","unstructured":"The Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group (2005) Etanercept plus standard therapy for Wegener\u2019s granulomatosis. N Engl J Med 352: 351\u2013361","journal-title":"N Engl J Med"},{"key":"324_CR2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/00016480500437435","volume":"126","author":"Bacciu","year":"2006","unstructured":"Bacciu A, Bacciu S, Mercante G et al. (2006) Ear, nose and throat manifestations of Churg-Strauss syndrome. Acta Otolaryngol 126: 503\u2013509","journal-title":"Acta Otolaryngol"},{"key":"324_CR3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MLG.0b013e318159889d","volume":"118","author":"Bacciu","year":"2008","unstructured":"Bacciu A, Buzio C, Giordano D et al. (2008) Nasal polyposis in Churg-Strauss syndrome. Laryngoscope 118: 325\u2013329","journal-title":"Laryngoscope"},{"key":"324_CR4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mai.2001.112374","volume":"107","author":"X","year":"2001","unstructured":"X Bachert C, Gevaert P, Holtappels G et al. (2001) Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 107: 607\u2013614","journal-title":"J Allergy Clin Immunol"},{"key":"324_CR5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11882-003-0065-y","volume":"3","author":"Bachert","year":"2003","unstructured":"Bachert C, Zele T van, Gevaert P et al. (2003) Superantigens and nasal polyps. Curr Allergy Asthma Rep 3: 523\u2013531","journal-title":"Curr Allergy Asthma Rep"},{"key":"324_CR6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0749-0704(02)00030-1","volume":"18","author":"Bandi","year":"2002","unstructured":"Bandi V, Munnur U, Braman SS (2002) Airway problems in patients with rheumatologic disorders. Crit Care Clin 18: 749\u2013765","journal-title":"Crit Care Clin"},{"key":"324_CR7","first-page":"359","volume":"146","author":"Bennett","year":"1987","unstructured":"Bennett RW, Staker LV (1987) Wegener\u2019s granulomatosis presenting as vertigo. West J Med 146: 359\u2013361","journal-title":"West J Med"},{"key":"324_CR8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1258\/0022215011907253","volume":"115","author":"Bibas","year":"2001","unstructured":"Bibas A, Fahy C, Sneddon L, Bowdler D (2001) Facial paralysis in Wegener\u2019s granulomatosis of the middle ear. J Laryngol Otol 115: 304\u2013306","journal-title":"J Laryngol Otol"},{"key":"324_CR9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1017\/S0022215100089362","volume":"94","author":"Calonius","year":"1980","unstructured":"Calonius IH, Christensen CK (1980) Hearing impairment and facial palsy as initial signs of Wegener\u2019s granulomatosis. J Laryngol Otol 94: 649\u2013657","journal-title":"J Laryngol Otol"},{"key":"324_CR10","first-page":"1584","volume":"28","author":"Choi","year":"2001","unstructured":"Choi HK, Liu S, Merkel PA et al. (2001) Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol 28: 1584\u20131590","journal-title":"J Rheumatol"},{"key":"324_CR11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/432735","volume":"192","author":"X","year":"2005","unstructured":"X Clement S, Vaudaux P, Francois P et al. (2005) Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis 192: 1023\u20131028","journal-title":"J Infect Dis"},{"key":"324_CR12","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1128\/CDLI.8.6.1064-1069.2001","volume":"8","author":"Cole","year":"2001","unstructured":"Cole AM, Tahk S, Oren A et al. (2001) Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 8: 1064\u20131069","journal-title":"Clin Diagn Lab Immunol"},{"key":"324_CR13","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/art.1780391215","volume":"39","author":"X","year":"1996","unstructured":"X De Groot K, Reinhold-Keller E, Tatsis E et al. (1996) Therapy for the maintenance of remission in sixty-five patients with generalized Wegener\u2019s granulomatosis. Methotrexate versus trimethoprim\/sulfamethoxazole. Arthritis Rheum 39: 2052\u20132061","journal-title":"Arthritis Rheum"},{"key":"324_CR14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/art.1780310821","volume":"31","author":"DeRemee","year":"1988","unstructured":"DeRemee RA (1988) The treatment of Wegener\u2019s granulomatosis with trimethoprim\/sulfamethoxazole: illusion or vision? Arthritis Rheum 31: 1068\u20131074","journal-title":"Arthritis Rheum"},{"key":"324_CR15","first-page":"777","volume":"51","author":"X","year":"1976","unstructured":"X DeRemee RA, McDonald TJ, Harrison EG Jr, Coles DT (1976) Wegener\u2019s granulomatosis. Anatomic correlates, a proposed classification. Mayo Clin Proc 51: 777\u2013781","journal-title":"Mayo Clin Proc"},{"key":"324_CR16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00000478-199006000-00006","volume":"14","author":"X","year":"1990","unstructured":"X Devaney KO, Travis WD, Hoffman G et al. (1990) Interpretation of head and neck biopsies in Wegener\u2019s granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 14: 555\u2013564","journal-title":"Am J Surg Pathol"},{"key":"324_CR17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000230229","volume":"37","author":"X","year":"1970","unstructured":"X Donovan R, Johansson SG, Bennich H, Soothill JF (1970) Immunoglobulins in nasal polyp fluid. Int Arch Allergy Appl Immunol 37: 154\u2013166","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"324_CR18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","volume":"98","author":"Fauci","year":"1983","unstructured":"Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener\u2019s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76\u201385","journal-title":"Ann Intern Med"},{"key":"324_CR19","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.1780330812","volume":"33","author":"X","year":"1990","unstructured":"X Fries JF, Hunder GG, Bloch DA et al. (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 33: 1135\u20131136","journal-title":"Arthritis Rheum"},{"key":"324_CR20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00106-004-1118-9","volume":"52","author":"X","year":"2004","unstructured":"X Gottschlich S, Ambrosch P, Gross WL, Hellmich B (2004) Wegener\u2019s granulomatosis in the head and neck region. HNO 52: 935\u2013945","journal-title":"HNO"},{"key":"324_CR21","first-page":"196","volume":"14","author":"Griffith","year":"1997","unstructured":"Griffith ME, Pusey CD (1997) HLA genes in ANCA-associated vasculitides. Exp Clin Immunogenet 14: 196\u2013205","journal-title":"Exp Clin Immunogenet"},{"key":"324_CR22","first-page":"15","volume":"6","author":"X","year":"1989","unstructured":"X Gross WL (1989) Wegener\u2019s granulomatosis. New aspects of the disease course, immunodiagnostic procedures, and stage-adapted treatment. Sarcoidosis 6: 15\u201329","journal-title":"Sarcoidosis"},{"key":"324_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002281-199401000-00003","volume":"6","author":"Gross","year":"1994","unstructured":"Gross WL (1994) New developments in the treatment of systemic vasculitis. Curr Opin Rheumatol 6: 11\u201319","journal-title":"Curr Opin Rheumatol"},{"key":"324_CR24","first-page":"1","volume":"91","author":"X","year":"1993","unstructured":"X Gross WL, Schmitt WH, Csernok E (1993) ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 91: 1\u201312","journal-title":"Clin Exp Immunol"},{"key":"324_CR25","unstructured":"Hagen EC (1997) Sinn und Unsinn der Anwendung von ANCA-Tests. In: Rasmussen N (Hrsg) Rheumatologie in Europa 26\/4: 126\u2013130"},{"key":"324_CR26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1017\/S0022215100133973","volume":"110","author":"Hern","year":"1996","unstructured":"Hern JD, Hollis LJ, Mochloulis G et al. (1996) Early diagnosis of Wegener\u2019s granulomatosis presenting with facial nerve palsy. J Laryngol Otol 110: 459\u2013461","journal-title":"J Laryngol Otol"},{"key":"324_CR27","first-page":"83","volume":"86","author":"Holl-Ulrich","year":"2002","unstructured":"Holl-Ulrich K, Reinhold-Keller E, Muller A, Feller AC (2002) Pathology of vasculitis: differential diagnosis and selected disorders. Verh Dtsch Ges Pathol 86: 83\u201390","journal-title":"Verh Dtsch Ges Pathol"},{"key":"324_CR28","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/00005537-200109000-00024","volume":"111","author":"Ishiyama","year":"2001","unstructured":"Ishiyama A, Canalis RF (2001) Otological manifestations of Churg-Strauss syndrome. Laryngoscope 111: 1619\u20131624","journal-title":"Laryngoscope"},{"key":"324_CR29","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1001\/archinte.1988.00380100131030","volume":"148","author":"Israel","year":"1988","unstructured":"Israel HL (1988) Sulfamethoxazole-trimethoprim therapy for Wegener\u2019s granulomatosis. Arch Intern Med 148: 2293\u20132295","journal-title":"Arch Intern Med"},{"key":"324_CR30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.autrev.2004.06.003","volume":"4","author":"X","year":"2005","unstructured":"X Jagiello P, Gross WL, Epplen JT (2005) Complex genetics of Wegener granulomatosis. Autoimmun Rev 4: 42\u201347","journal-title":"Autoimmun Rev"},{"key":"324_CR31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"X","year":"1994","unstructured":"X Jennette JC, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187\u2013192","journal-title":"Arthritis Rheum"},{"key":"324_CR32","first-page":"188","volume":"36","author":"Jennings","year":"1998","unstructured":"Jennings CR, Jones NS, Dugar J et al. (1998) Wegener\u2019s granulomatosis\u2013a review of diagnosis and treatment in 53 subjects. Rhinology 36: 188\u2013191","journal-title":"Rhinology"},{"key":"324_CR33","doi-asserted-by":"crossref","unstructured":"X Lamprecht P, Voswinkel J, Lilienthal T et al. (2002) Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener\u2019s granulomatosis. Rheumatology (Oxford) 41: 1303\u20131307","DOI":"10.1093\/rheumatology\/41.11.1303"},{"key":"324_CR34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"X","year":"1990","unstructured":"X Leavitt RY, Fauci AS, Bloch DA et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum 33: 1101\u20131107","journal-title":"Arthritis Rheum"},{"key":"324_CR35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0463.1990.tb05707.x","volume":"19","author":"Lehmann","year":"1990","unstructured":"Lehmann H, Kiefer B (1990) Clinical manifestations of Wegener\u2019s granulomatosis. APMIS Suppl 19: 19\u201320","journal-title":"APMIS Suppl"},{"key":"324_CR36","first-page":"261","volume":"26","author":"X","year":"1997","unstructured":"X Lie JT (1997) Wegener\u2019s granulomatosis: histological documentation of common and uncommon manifestations in 216 patients. Vasa 26: 261\u2013270","journal-title":"Vasa"},{"key":"324_CR37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","volume":"51","author":"Mahr","year":"2004","unstructured":"Mahr A, Guillevin L, Poissonnet M, Ayme S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51: 92\u201399","journal-title":"Arthritis Rheum"},{"key":"324_CR38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/019459988008800512","volume":"88","author":"McCaffrey","year":"1980","unstructured":"McCaffrey TV, McDonald TJ, Facer GW, DeRemee RA (1980) Otologic manifestations of Wegener\u2019s granulomatosis. Otolaryngol Head Neck Surg 88: 586\u2013593","journal-title":"Otolaryngol Head Neck Surg"},{"key":"324_CR39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1288\/00005537-198302000-00020","volume":"93","author":"McDonald","year":"1983","unstructured":"McDonald TJ, DeRemee RA (1983) Wegener\u2019s granulomatosis. Laryngoscope 93: 220\u2013231","journal-title":"Laryngoscope"},{"key":"324_CR40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-4757-9182-2_49","volume":"336","author":"McDonald","year":"1993","unstructured":"McDonald TJ, DeRemee RA (1993) Head and neck involvement in Wegener\u2019s granulomatosis (WG). Adv Exp Med Biol 336: 309\u2013313","journal-title":"Adv Exp Med Biol"},{"key":"324_CR41","first-page":"iv31","volume":"Dis","author":"X","year":"2005","unstructured":"X Mukhtyar C, Luqmani R (2005) Current state of tumour necrosis factor {alpha} blockade in Wegener\u2019s granulomatosis. Ann Rheum Dis (Suppl 4) 64: iv31\u2013iv36","journal-title":"Ann Rheum"},{"key":"324_CR42","doi-asserted-by":"crossref","unstructured":"Mygind N, Dahl R, Bachert C (2000) Nasal polyposis, eosinophil dominated inflammation, and allergy. Thorax (Suppl 2) 55: S79\u2013S83","DOI":"10.1136\/thorax.55.suppl_2.S79"},{"key":"324_CR43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bdj.4808316","volume":"175","author":"Napier","year":"1993","unstructured":"Napier SS, Allen JA, Irwin CR, McCluskey DR (1993) \u201aStrawberry gums\u2019\u2013a case of Wegener\u2019s granulomatosis. Br Dent J 175: 327\u2013329","journal-title":"Br Dent J"},{"key":"324_CR44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s004050100327","volume":"258","author":"Nikolaou","year":"2001","unstructured":"Nikolaou AC, Vlachtsis KC, Daniilidis MA et al. (2001) Wegener\u2019s granulomatosis presenting with bilateral facial nerve palsy. Eur Arch Otorhinolaryngol 258: 198\u2013202","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"324_CR45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/000348949810700515","volume":"107","author":"O","year":"1998","unstructured":"O\u2019Devaney K, Ferlito A, Hunter BC et al. (1998) Wegener\u2019s granulomatosis of the head and neck. Ann Otol Rhinol Laryngol 107: 439\u2013445","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"324_CR46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5387\/fms.46.31","volume":"46","author":"Ohtani","year":"2000","unstructured":"Ohtani I, Baba Y, Suzuki C et al. (2000) Temporal bone pathology in Wegener\u2019s granulomatosis. Fukushima J Med Sci 46: 31\u201339","journal-title":"Fukushima J Med Sci"},{"key":"324_CR47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s003930170047","volume":"60","author":"X","year":"2001","unstructured":"X Paulsen JI, Rudert H (2001) Manifestations of primary vasculitis in the ENT region. Z Rheumatol 60: 219\u2013225","journal-title":"Z Rheumatol"},{"key":"324_CR48","first-page":"69","volume":"31","author":"Pirsig","year":"1993","unstructured":"Pirsig W, Pentz S, Lenders H (1993) Repair of saddle nose deformity in Wegener\u2019s granulomatosis and ectodermal dysplasia. Rhinology 31: 69\u201372","journal-title":"Rhinology"},{"key":"324_CR49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrmicro1384","volume":"4","author":"Proctor","year":"2006","unstructured":"Proctor RA, Eiff C von, Kahl BC et al. (2006) Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4: 295\u2013305","journal-title":"Nat Rev Microbiol"},{"key":"324_CR50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0463.1990.tb05740.x","volume":"19","author":"Rasmussen","year":"1990","unstructured":"Rasmussen N, Petersen J, Remvig L, Andersen V (1990) Treatment of Wegener\u2019s granulomatosis with trimethoprim-sulfamethoxazole. APMIS Suppl 19: 61\u201362","journal-title":"APMIS Suppl"},{"key":"324_CR51","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","volume":"43","author":"X","year":"2000","unstructured":"X Reinhold-Keller E, Beuge N, Latza U et al. (2000) An interdisciplinary approach to the care of patients with Wegener\u2019s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43: 1021\u20131032","journal-title":"Arthritis Rheum"},{"key":"324_CR52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.qjmed.a030133","volume":"89","author":"X","year":"1996","unstructured":"X Reinhold-Keller E, De Groot K, Rudert H et al. (1996) Response to trimethoprim\/sulfamethoxazole in Wegener\u2019s granulomatosis depends on the phase of disease. QJM 89: 15\u201323","journal-title":"QJM"},{"key":"324_CR53","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1398-9995.2005.00902.x","volume":"60","author":"Riechelmann","year":"2005","unstructured":"Riechelmann H, Essig A, Deutschle T et al. (2005) Nasal carriage of Staphylococcus aureus in house dust mite allergic patients and healthy controls. Allergy 60: 1418\u20131423","journal-title":"Allergy"},{"key":"324_CR54","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.micinf.2007.01.015","volume":"9","author":"X","year":"2007","unstructured":"X Rosenstiel P, Till A, Schreiber S (2007) NOD-like receptors and human diseases. Microbes Infect 9: 648\u2013657","journal-title":"Microbes Infect"},{"key":"324_CR55","first-page":"41S","volume":"125","author":"Rusterholz","year":"2000","unstructured":"Rusterholz D, Schlegel C (2000) Infectious aspects of Wegener\u2019s granulomatosis. Schweiz Med Wochenschr Suppl 125: 41S\u201343S","journal-title":"Schweiz Med Wochenschr Suppl"},{"key":"324_CR56","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","volume":"121","author":"Sandborn","year":"2001","unstructured":"Sandborn WJ, Hanauer SB, Katz S et al. (2001) Etanercept for active Crohn\u2019s disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 121: 1088\u20131094","journal-title":"Gastroenterology"},{"key":"324_CR57","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2222.2007.02889.x","volume":"38","author":"X","year":"2008","unstructured":"X Scadding GK, Durham SR, Mirakian R et al. (2008) BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 38: 260\u2013275","journal-title":"Clin Exp Allergy"},{"key":"324_CR58","first-page":"103","volume":"Pharmacol","author":"X","year":"2005","unstructured":"X Schafer D, Baenkler HW (2005) Functional eicosanoid test and typing (FET) of peripheral blood cells in eicosanoids related diseases. J Physiol Pharmacol (Suppl 5) 56: 103\u2013118","journal-title":"J Physiol"},{"key":"324_CR59","first-page":"376","volume":"6","author":"X","year":"2005","unstructured":"X Schreiber S, Rosenstiel P, Albrecht M et al. (2005) Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 6: 376\u2013388","journal-title":"Nat Rev Genet"},{"key":"324_CR60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s003930070079","volume":"59","author":"X","year":"2000","unstructured":"X Schwarz-Eywill M, Weiss A, Unger L, Nusslein H (2000) Relevance of a standardized staging study in patients with systemic vasculitis. Z Rheumatol 59: 183\u2013190","journal-title":"Z Rheumatol"},{"key":"324_CR61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0091-6749(77)90171-3","volume":"59","author":"X","year":"1977","unstructured":"X Settipane GA, Chafee FH (1977) Nasal polyps in asthma and rhinitis. A review of 6,037 patients. J Allergy Clin Immunol 59: 17\u201321","journal-title":"J Allergy Clin Immunol"},{"key":"324_CR62","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archotol.1992.01880070101021","volume":"118","author":"Slavin","year":"1992","unstructured":"Slavin RG (1992) Allergy is not a significant cause of nasal polyps. Arch Otolaryngol Head Neck Surg 118: 771","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"324_CR63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","volume":"335","author":"X","year":"1996","unstructured":"X Stegeman CA, Tervaert JW, De Jong PE, Kallenberg CG (1996) Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener\u2019s granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 335: 16\u201320","journal-title":"N Engl J Med"},{"key":"324_CR64","doi-asserted-by":"crossref","first-page":"338","DOI":"10.14219\/jada.archive.2007.0166","volume":"138","author":"Stewart","year":"2007","unstructured":"Stewart C, Cohen D, Bhattacharyya I et al. (2007) Oral manifestations of Wegener\u2019s granulomatosis: a report of three cases and a literature review. J Am Dent Assoc 138: 338\u2013348","journal-title":"J Am Dent Assoc"},{"key":"324_CR65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00002281-200001000-00006","volume":"12","author":"Stone","year":"2000","unstructured":"Stone JH, Francis HW (2000) Immune-mediated inner ear disease. Curr Opin Rheumatol 12: 32\u201340","journal-title":"Curr Opin Rheumatol"},{"key":"324_CR66","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO;2-F","volume":"44","author":"Stone","year":"2001","unstructured":"Stone JH, Uhlfelder ML, Hellmann DB et al. (2001) Etanercept combined with conventional treatment in Wegener\u2019s granulomatosis: a six-month open-label trial to evaluate safety. Arthritis Rheum 44: 1149\u20131154","journal-title":"Arthritis Rheum"},{"key":"324_CR67","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"Targan","year":"1997","unstructured":"Targan SR, Hanauer SB, Van Deventer SJ et al. (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. Crohn\u2019s Disease cA2 Study Group. N Engl J Med 337: 1029\u20131035","journal-title":"N Engl J Med"},{"key":"324_CR68","first-page":"181","volume":"14","author":"Tos","year":"1992","unstructured":"Tos M, Sasaki Y, Ohnishi M et al. (1992) Fireside conference 2. Pathogenesis of nasal polyps. Rhinol Suppl 14: 181\u2013185","journal-title":"Rhinol Suppl"},{"key":"324_CR69","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jaci.2004.07.013","volume":"114","author":"X","year":"2004","unstructured":"X Zele T van, Gevaert P, Watelet JB et al. (2004) Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 114: 981\u2013983","journal-title":"J Allergy Clin Immunol"},{"key":"324_CR70","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1086\/507643","volume":"43","author":"Vaudaux","year":"2006","unstructured":"Vaudaux P, Kelley WL, Lew DP (2006) Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat. Clin Infect Dis 43: 968\u2013970","journal-title":"Clin Infect Dis"},{"key":"324_CR71","first-page":"35","volume":"Pharmacol","author":"Velten","year":"2006","unstructured":"Velten FW, Bayerl C, Baenkler HW, Schaefer D (2006) Functional eicosanoid test and typing (FET) in acetylsalicylic acid intolerant patients with urticaria. J Physiol Pharmacol (Suppl 12) 57: 35\u201346","journal-title":"J Physiol"},{"key":"324_CR72","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/320519","volume":"32","author":"Eiff","year":"2001","unstructured":"Eiff C von, Becker K, Metze D et al. (2001) Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier\u2019s disease. Clin Infect Dis 32: 1643\u20131647","journal-title":"Clin Infect Dis"},{"key":"324_CR73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1096\/fj.04-2073fje","volume":"19","author":"X","year":"2005","unstructured":"X Waetzig GH, Rosenstiel P, Arlt A et al. (2005) Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1. FASEB J 19: 91\u201393","journal-title":"FASEB J"},{"key":"324_CR74","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1097\/00054725-200402001-00009","volume":"Dis","author":"Waetzig","year":"2004","unstructured":"Waetzig GH, Schreiber S (2004) Mechanisms of infliximab: the reverse side of a drug effect. Inflamm Bowel Dis (Suppl 1) 10: S38\u2013S43","journal-title":"Inflamm Bowel"},{"key":"324_CR75","first-page":"36","volume":"102","author":"Wegener","year":"1939","unstructured":"Wegener F (1939) \u00dcber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. Beitr Pathol Anatom 102: 36\u201368","journal-title":"Beitr Pathol Anatom"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0324-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-008-0324-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0324-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T02:25:19Z","timestamp":1709087119000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-008-0324-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,5]]},"references-count":75,"alternative-id":["324"],"URL":"https:\/\/doi.org\/10.1007\/s00393-008-0324-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,5]]}}}